Not logged in.png)
Share.png)
SaveShare Save Share Save A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared with PCV13 in healthy infants (PNEU-PED-EU-1) (vol 41, pg 3387, 2023)
Martinon-Torres, Federico; Wysocki, Jacek; Szenborn, Leszek; Carmona-Martinez, Alfonso; Poder, Airi; Dagan, Ron; Richmond, Peter; Gilbert, Christopher; Trudel, Marie-Chantale; Flores, Sheryl; Lupinacci, Robert; Mcfetridge, Richard; Wiedmann, Richard T.; Chen, Qiuxu; Gerrits, Han; Banniettis, Natalie; Musey, Luwy; Bickham, Kara; Kaminski, Janusz Share Save Share Save Lower Respiratory Tract Infections Following Respiratory Syncytial Virus Monoclonal Antibody Nirsevimab Immunization Versus Placebo: Analysis From a Phase 3 Randomized Clinical Trial (MELODY)Arbetter, Doug; Gopalakrishnan, Vancheswaran; Aksyuk, Anastasia A.; Ahani, Bahar; Chang, Yue; Dagan, Ron; Esser, Mark T.; Hammitt, Laura L.; Mankad, Vaishali S.; Saez-Llorens, Xavier; Shen, David; Leach, Amanda; Kelly, Elizabeth J.; Villafana, Tonya; Wilkins, Deidre Share Save The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global accessTerstappen, Jonne; Hak, Sarah F.; Bhan, Anant; Bogaert, Debby; Bont, Louis J.; Buchholz, Ursula J.; Clark, Andrew; Cohen, Cheryl; Dagan, Ron; Feikin, Daniel R.; Graham, Barney S.; Gupta, Anuradha; Haldar, Pradeep; Jalang'o, Rose; Karron, Ruth A.; Kragten, Leyla; Li, You; Lowensteyn, Yvette N.; Munywoki, Patrick K.; Njogu, Rosemary; Osterhaus, Ab; Pollard, Andrew J.; Nazario, Luiza Reali; Sande, Charles; Satav, Ashish R.; Srikantiah, Padmini; Stein, Renato; Thacker, Naveen; Thomas, Rachael; Bayona, Marta Tufet; Mazur, Natalie Share Save Share Save Share Save Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trials (Vol 14, 4347, 2023)Ahani, Bahar; Tuffy, Kevin M.; Aksyuk, Anastasia A.; Wilkins, Deidre; Abram, Michael E.; Dagan, Ron; Domachowske, Joseph B.; Guest, Johnathan D.; Ji, Hong; Kushnir, Anna; Leach, Amanda; Madhi, Shabir A.; Mankad, Vaishali S.; Simoes, Eric A. F.; Sparklin, Benjamin; Speer, Scott D.; Stanley, Ann Marie; Tabor, David E.; Hamren, Ulrika Wahlby; Kelly, Elizabeth J.; Villafana, Tonya Share Save Testing the performance, adequacy, and applicability of an artificial intelligence model for pediatric pneumonia diagnosisDominguez-Rodriguez, Sara; Liz-Lopez, Helena; Panizo-LLedot, Angel; Ballesteros, Alvaro; Dagan, Ron; Greenberg, David; Gutierrez, Lourdes; Rojo, Pablo; Otheo, Enrique; Galan, Juan Carlos; Villanueva, Sara; Garcia, Sonsoles; Mosquera, Pablo; Tagarro, Alfredo; Moraleda, Cinta; Camacho, David Share Save Share Save Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trialsAhani, Bahar; Tuffy, Kevin M.; Aksyuk, Anastasia A.; Wilkins, Deidre; Abram, Michael E.; Dagan, Ron; Domachowske, Joseph B.; Guest, Johnathan D.; Ji, Hong; Kushnir, Anna; Leach, Amanda; Madhi, Shabir A.; Mankad, Vaishali S.; Simoes, Eric A. F.; Sparklin, Benjamin; Speer, Scott D.; Stanley, Ann Marie; Tabor, David E.; Hamren, Ulrika Wahlby; Kelly, Elizabeth J.; Villafana, Tonya Share Save Share Save A Phase 3, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate Safety, Tolerability, and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Allogeneic Hematopoietic Cell Transplant Recipients (PNEU-STEM)Wilck, Marissa; Cornely, Oliver A.; Cordonnier, Catherine; Diego Velez, Juan; Ljungman, Per; Maertens, Johan; Selleslag, Dominik; Mullane, Kathleen M.; Nabhan, Samir; Chen, Qiuxu; Dagan, Ron; Richmond, Peter; Daus, Caroline; Geddie, Kateasha; Tamms, Gretchen; Sterling, Tina; Patel, Shrita M.; Shekar, Tulin; Musey, Luwy; Buchwald, Ulrike K. Share Save Safety and Tolerability of V114 Pneumococcal Vaccine in Infants: A Phase 3 StudyBanniettis, Natalie; Horn, Michael; Sadarangani, Manish M.; Patel, Shrita M.; Greenberg, David; Oberdorfer, Peninnah P.; Klein, Nicola P.; Rupp, Richard; Dagan, Ron; Richmond, Peter; Lumley, Jessie; Zhou, Wei; Shi, Yaru; Tamms, Gretchen; Feemster, Kristen; Lupinacci, Robert; Musey, Luwy; Bickham, Kara Share Save Nirsevimab for Prevention of RSV in Term and Late-Preterm InfantsMuller, William J.; Madhi, Shabir A.; Seoane Nunez, Beatriz; Baca Cots, Manuel; Bosheva, Miroslava; Dagan, Ron; Hammitt, Laura L.; Llapur, Conrado J.; Novoa, Jose M.; Llorens, Xavier Saez; Grenham, Amy; Kelly, Elizabeth J.; Mankad, Vaishali S.; Shroff, Manish; Takas, Therese; Leach, Amanda; Villafana, Tonya Share Save Share Save A phase 3 study of safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine, in children with HIVWilck, Marissa; Barnabas, Shaun; Chokephaibulkit, Kulkanya; Violari, Avy; Kosalaraksa, Pope; Yesypenko, Svitlana; Chukhalova, Iryna; Dagan, Ron; Richmond, Peter; Mikviman, Elena; Morgan, Leslie; Feemster, Kristen; Lupinacci, Robert; Chiarappa, Joseph A.; Madhi, Shabir; Bickham, Kara; Musey, Luwy Share Save Phase 3 trial to evaluate the safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine 6 months later, in at-risk adults 18-49 years of age (PNEU-DAY): A subgroup analysis by baseline risk factorsHammitt, Laura L.; Quinn, Dean; Janczewska, Ewa; Pasquel, Francisco J.; Tytus, Richard; Reddy, K. Rajender; Abarca, Katia; Khaertynova, Ilsiyar M. M.; Dagan, Ron; Dawson, Rachel; McCauley, Jennifer; Shekar, Tulin; Fu, Wei; Pedley, Alison; Sterling, Tina; Tamms, Gretchen; Musey, Luwy; Buchwald, Ulrike K. Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
